MedPath

Effect of Saffron in Coronary Artery Diseases

Phase 3
Conditions
Coronary Artery Diseases.
Atherosclerotic heart disease of native coronary artery
I25.1
Registration Number
IRCT20220902055853N2
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Coronary artery occlusion disease
Willingness to participate in the study
Age range of 40 to 65 years
BMI 25-35

Exclusion Criteria

Having heart attack
lactation or pregnancy
Having any infectious disease
Chang the usual medications
Irregular consumption of interventional capsules
Taking food supplement, vitamin and mineral for at least in the last 3 months
Participate in another trial simultaneously
Having an Allergic reaction to interventional herb

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hs-CRP. Timepoint: At the beginning and end of study. Method of measurement: Serum sample.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath